B. Aydin Et Al. , "MicroRNA-Mediated Drug Repurposing Unveiled Potential Candidate Drugs for Prolactinoma Treatment," NEUROENDOCRINOLOGY , vol.112, pp.161-173, 2022
Aydin, B. Et Al. 2022. MicroRNA-Mediated Drug Repurposing Unveiled Potential Candidate Drugs for Prolactinoma Treatment. NEUROENDOCRINOLOGY , vol.112 , 161-173.
Aydin, B., Arslan, S., BAYRAKLI, F., YILMAZ, B., & ARĞA, K. Y., (2022). MicroRNA-Mediated Drug Repurposing Unveiled Potential Candidate Drugs for Prolactinoma Treatment. NEUROENDOCRINOLOGY , vol.112, 161-173.
Aydin, Busra Et Al. "MicroRNA-Mediated Drug Repurposing Unveiled Potential Candidate Drugs for Prolactinoma Treatment," NEUROENDOCRINOLOGY , vol.112, 161-173, 2022
Aydin, Busra Et Al. "MicroRNA-Mediated Drug Repurposing Unveiled Potential Candidate Drugs for Prolactinoma Treatment." NEUROENDOCRINOLOGY , vol.112, pp.161-173, 2022
Aydin, B. Et Al. (2022) . "MicroRNA-Mediated Drug Repurposing Unveiled Potential Candidate Drugs for Prolactinoma Treatment." NEUROENDOCRINOLOGY , vol.112, pp.161-173.
@article{article, author={Busra Aydin Et Al. }, title={MicroRNA-Mediated Drug Repurposing Unveiled Potential Candidate Drugs for Prolactinoma Treatment}, journal={NEUROENDOCRINOLOGY}, year=2022, pages={161-173} }